Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2022-10-28 00:00:00 ET · period of report 2022-10-27 · accession 0001209191-22-054879 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 | 2022-10-27 | ORMP | KIDRON NADAV | Pres, CEO, Dir | G - Gift | $0.00 | -25.0K | 1.05M | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-27 | G | D | 25,000 | $0.00 | 1,053,098 | D | — | — | (F1) This transaction represents a charitable donation effective October 27, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares. |